Molecular Templates, Inc. Collaboration Agreements
5 Contracts & Agreements
Amendment No. 1 to Collaboration Agreement, dated December 2, 2021, by and between the Company and Bristol-Myers Squibb Company
(Filed With SEC on March 29, 2022)
Collaboration Agreement by and between Molecular Templates, Inc. and Bristol-Myers Squibb Company dated February 10, 2021
(Filed With SEC on May 14, 2021)
First Amendment to the Development Collaboration and Exclusive License Agreement, dated as of July 18, 2019, by and between Molecular Templates, Inc. and Millennium...
(Filed With SEC on November 12, 2019)
Multi-License Collaboration and License Agreement, dated June 23, 2017, between Molecular Templates OpCo and Millennium Pharmaceuticals, Inc. (a wholly owned subsidiary of Takeda...
(Filed With SEC on October 17, 2017)
CONFIDENTIAL TREATMENT REQUESTED Research Collaboration and Option Agreement
(Filed With SEC on May 15, 2017)